Skip to main content
GILD
NASDAQ Life Sciences

Lenacapavir Doubles One-Year PrEP Persistence vs Daily Pills in PURPOSE 5

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$167.815
Mkt Cap
$208.147B
52W Low
$116.88
52W High
$176.58
52W Position info
44% above low
Off High info
5.0% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

GILD sits 44% above its 52-week low of $116.88 on light trading volume (0.2× avg).

Summary

PURPOSE 5 randomized 267 people in the UK and France not currently on PrEP: 85.6% of those on twice-yearly lenacapavir injections stayed persistent through Week 52 versus 46.3% on daily oral F/TDF, a 39.3-point gap that was statistically significant. Nobody on lenacapavir acquired HIV during the year; one infection occurred in the F/TDF arm. This is the first randomized head-to-head showing the long-acting shot keeps people on prevention, which is the commercial argument for Yeztugo against cheap generic daily pills. Safety looked consistent with earlier studies — injection-site nodules in 67.8% and pain in 60.0%, but no lenacapavir discontinuations from adverse events. Data are being presented at HIV Glasgow 2026, and the persistence gap is the number payers and prescribers will weigh as Yeztugo rolls out.

At the time of this announcement, GILD was trading at $167.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $208.1B. The 52-week trading range was $116.88 to $176.58. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $168.01 info
Change: -$6.56 (-4%) info
Market Cap: $208.414B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $168.01 info
Change: +$2.13 (+1%) info
Market Cap: $208.414B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $168.01 info
Change: +$4.01 (+2%) info
Market Cap: $208.414B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $168.01 info
Change: +$10.82 (+7%) info
Market Cap: $208.414B info
GILD
Oct 19, 2026, 6:40 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $156.82
Real-time Price: $168.01 info
Change: +$11.19 (+7%) info
Market Cap: $208.414B info